Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints
- PMID: 3060249
- DOI: 10.1016/0165-4608(88)90082-9
Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints
Erratum in
- Cancer Genet Cytogenet 1989 Mar;38(1):141. Berheimm A [corrected to Bernheim A]
Abstract
Cytogenetic studies are reported on 17 T-cell malignant lymphomas (ML) including six cutaneous T-cell malignant lymphomas (CTCL). Due to the low incidence of rearrangements on bands where the T-cell receptor genes are located, other cases reported in the literature were analyzed in order to estimate the most frequent chromosomal breakpoints in ML, CTCL, and adult T-cell leukemia-lymphoma. Besides chromosomes 1 and 6q, 14q11, 7p15p21, and 7q32q35, the most frequent rearrangements involved bands 14q32, 2p11-p14, 2p23-p25, 17cen, 9p21p23, and 10p13p15. These results show that molecular studies must be concentrated on these chromosomal regions in order to identify the DNA sequences that may be involved in T-cell malignancies.
Similar articles
-
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.Br J Dermatol. 2002 Sep;147(3):464-75. doi: 10.1046/j.1365-2133.2002.04966.x. Br J Dermatol. 2002. PMID: 12207585
-
Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities.Genes Chromosomes Cancer. 2006 Apr;45(4):383-91. doi: 10.1002/gcc.20302. Genes Chromosomes Cancer. 2006. PMID: 16382449
-
Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin.J Invest Dermatol. 1982 Jan;78(1):69-75. doi: 10.1111/1523-1747.ep12497947. J Invest Dermatol. 1982. PMID: 6976392
-
Genotyping of cutaneous T-cell lymphomas and pseudolymphomas.Curr Probl Dermatol. 1990;19:114-23. doi: 10.1159/000418081. Curr Probl Dermatol. 1990. PMID: 2404672 Review. No abstract available.
-
Lymphomas and dysproteinaemias.Clin Haematol. 1980 Feb;9(1):175-93. Clin Haematol. 1980. PMID: 6768482 Review. No abstract available.
Cited by
-
BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.Int J Hematol. 2005 Jul;82(1):42-7. doi: 10.1532/IJH97.05013. Int J Hematol. 2005. PMID: 16105758
-
Acute lymphoblastic leukemia in children and SALL4 and BMI-1 gene expression.Pediatr Res. 2023 Oct;94(4):1510-1515. doi: 10.1038/s41390-021-01854-3. Epub 2021 Nov 15. Pediatr Res. 2023. PMID: 34782707
-
Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity.Mol Cell Biol. 1996 Oct;16(10):5527-35. doi: 10.1128/MCB.16.10.5527. Mol Cell Biol. 1996. PMID: 8816465 Free PMC article.
-
Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.BMC Cancer. 2017 Jan 25;17(1):76. doi: 10.1186/s12885-017-3049-3. BMC Cancer. 2017. PMID: 28122538 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials